In the past few weeks, devastating storms have forced people out of their homes and away from their cancer care facilities, highlighting a need for better education and preparedness surrounding the medical consequences of natural disasters. Click here for tips to help minimize the harm that a natural disaster or public emergency can cause to your personal health.
On July 23rd, over 300 bone marrow and stem cell transplant patients and families, staff members and physicians boarded the Hornblower Infinity to celebrate life after transplant on our annual boat cruise.
On August 2, the United States Food and Drug Administration (FDA) approved the drug ibrutinib for treatment of adults with chronic graft versus host disease (cGVHD).
Kerry McDuffee, an inpatient nurse within the Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP) Bone Marrow and Stem Cell Transplant Program, was named a June 2017 DAISY Award Honoree in recognition of the care and compassion that she provides patients and their families.
This Fourth of July holiday, we’re not only celebrating the red, white and blue that honors the independence and freedom of our country, but also freedom from cancer and the cancer “blues.” Feeling this sense of freedom may mean that you’re cancer-free or that you’re unwilling to let a cancer diagnosis define you.
The Bone Marrow Transplant (BMT) Tandem meetings are the premier international conference on stem cell transplantation. Held in February 2017 in Orlando, Florida, the BMT Tandem Meetings serve as the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT). The CIBMTR and ASBMT are the two leading organizations for dedicated to advancing the field of bone marrow transplantation.
On January 15-17, 2017, the 4th Worldwide Network for Blood and Marrow Transplantation Workshop was held at the King Faisal Research and Cancer Center in Rhyadh, Saudi Arabia.
Dr. Usama Gergis of the Weill Cornell Medicine and NewYork-Presbyterian Bone Marrow Transplant Program served as session chair and moderator for a symposium on the long-term complications of bone marrow transplantation.